<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>251</number>
    <updateDate>2023-01-11T20:05:52Z</updateDate>
    <updateDateIncludingText>2023-01-11T20:05:52Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2007-01-10</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2007-01-10T22:19:55Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2007-01-10</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2007-01-10</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>V000127</bioguideId>
        <fullName>Sen. Vitter, David [R-LA]</fullName>
        <firstName>David</firstName>
        <lastName>Vitter</lastName>
        <party>R</party>
        <state>LA</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000595</bioguideId>
        <fullName>Sen. DeMint, Jim [R-SC]</fullName>
        <firstName>James</firstName>
        <lastName>DeMint</lastName>
        <party>R</party>
        <state>SC</state>
        <middleName>W.</middleName>
        <sponsorshipDate>2007-01-10</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000250</bioguideId>
        <fullName>Sen. Thune, John [R-SD]</fullName>
        <firstName>John</firstName>
        <lastName>Thune</lastName>
        <party>R</party>
        <state>SD</state>
        <middleName>R.</middleName>
        <sponsorshipDate>2007-06-12</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative fees</name>
        </item>
        <item>
          <name>Administrative procedure</name>
        </item>
        <item>
          <name>Administrative remedies</name>
        </item>
        <item>
          <name>Africa (Sub-Saharan)</name>
        </item>
        <item>
          <name>Australia</name>
        </item>
        <item>
          <name>Austria</name>
        </item>
        <item>
          <name>Belgium</name>
        </item>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Canada</name>
        </item>
        <item>
          <name>Civil actions and liability</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Consumer education</name>
        </item>
        <item>
          <name>Consumer protection</name>
        </item>
        <item>
          <name>Damages</name>
        </item>
        <item>
          <name>Denmark</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>East Asia</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Electronic government information</name>
        </item>
        <item>
          <name>Europe</name>
        </item>
        <item>
          <name>Evidence (Law)</name>
        </item>
        <item>
          <name>Federal Trade Commission</name>
        </item>
        <item>
          <name>Federal-state relations</name>
        </item>
        <item>
          <name>Finland</name>
        </item>
        <item>
          <name>Foreign Trade and International Finance</name>
        </item>
        <item>
          <name>France</name>
        </item>
        <item>
          <name>Germany</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government paperwork</name>
        </item>
        <item>
          <name>Government publicity</name>
        </item>
        <item>
          <name>Governmental investigations</name>
        </item>
        <item>
          <name>Greece</name>
        </item>
        <item>
          <name>Iceland</name>
        </item>
        <item>
          <name>Identification devices</name>
        </item>
        <item>
          <name>Import restrictions</name>
        </item>
        <item>
          <name>Imports</name>
        </item>
        <item>
          <name>Independent regulatory commissions</name>
        </item>
        <item>
          <name>Injunctions</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Internet</name>
        </item>
        <item>
          <name>Ireland</name>
        </item>
        <item>
          <name>Israel</name>
        </item>
        <item>
          <name>Italy</name>
        </item>
        <item>
          <name>Japan</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Licenses</name>
        </item>
        <item>
          <name>Liechtenstein</name>
        </item>
        <item>
          <name>Limitation of actions</name>
        </item>
        <item>
          <name>Luxembourg</name>
        </item>
        <item>
          <name>Netherlands</name>
        </item>
        <item>
          <name>New Zealand</name>
        </item>
        <item>
          <name>Norway</name>
        </item>
        <item>
          <name>Oceania</name>
        </item>
        <item>
          <name>Packaging</name>
        </item>
        <item>
          <name>Parties to actions</name>
        </item>
        <item>
          <name>Patent infringement</name>
        </item>
        <item>
          <name>Patents</name>
        </item>
        <item>
          <name>Pharmacies</name>
        </item>
        <item>
          <name>Pharmacists</name>
        </item>
        <item>
          <name>Portugal</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
        <item>
          <name>Price discrimination</name>
        </item>
        <item>
          <name>Product counterfeiting</name>
        </item>
        <item>
          <name>Product safety</name>
        </item>
        <item>
          <name>Punitive damages</name>
        </item>
        <item>
          <name>Restrictive trade practices</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>South Africa</name>
        </item>
        <item>
          <name>Spain</name>
        </item>
        <item>
          <name>Sweden</name>
        </item>
        <item>
          <name>Switzerland</name>
        </item>
        <item>
          <name>Telephone</name>
        </item>
        <item>
          <name>United Kingdom</name>
        </item>
        <item>
          <name>Web sites</name>
        </item>
        <item>
          <name>Wholesale trade</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2007-01-10</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2007-02-17T15:36:18Z</updateDate>
        <text><![CDATA[ <p>Pharmaceutical Market Access Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, and wholesalers to import qualifying drugs from certain countries into the United States.</p> <p>Sets forth registration requirements for exporters.</p> <p>Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters.</p> <p>Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies.</p> <p>Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order.</p> <p>Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement.</p> <p>Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug.</p> <p>Allows the Secretary to suspend or terminate the registration of an exporter for failing to maintain substantial compliance with all registration conditions.</p>]]></text>
      </summary>
    </summaries>
    <title>Pharmaceutical Market Access Act of 2007</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Pharmaceutical Market Access Act of 2007</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Pharmaceutical Market Access Act of 2007</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2007-01-10T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110s251is/xml/BILLS-110s251is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2007-01-10</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
